Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 31st October 2014
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Google aims to develop cancer diagnosis pill
microscope
The pill will work in conjunction will a wrist sensor.
Nano-particle pill could detect early warning signs before symptoms appear

Google's research arm, Google X, is working to develop technology that can detect cancer, heart attacks and other diseases before physical symptoms even appear.

Researchers led by molecular biologist, Dr Andrew Connor, hope to develop a pill that works in conjunction with a sensor worn on the wrist.

Nano-particles that detect disease will enter the bloodstream when the pill is swallowed while the sensor monitors the blood for early warning signs of disease.

Dr Connor told BBC News: "What we are trying to do is change medicine from reactive and transactional to proactive and preventative.

"Nanoparticles... give you the ability to explore the body at a molecular and cellular level."

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here. 

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com